Q3 2021 Aurobindo Pharma Ltd Earnings Call Transcript

Feb 11, 2021 / 03:00AM GMT
Operator

Good morning, ladies and gentlemen. Welcome to the Aurobindo Pharma Limited Q3 FY '21 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand the conference over to Mr. Krishna Kiran. Thank you, and over to you, sir.

Krishna Kiran - Aurobindo Pharma Limited - IR Officer

Thank you, Jessie. Good morning, and a warm welcome to our third quarter FY '21 earnings call. I am Krishna Kiran from Aurobindo Pharma Investor Relations. We hope you have received the Q3 financials and the press release that we've sent out yesterday. These are also available on our website.

With me, we have our senior management team, represented by Mr. N. Govindarajan, Managing Director; Mr. Sanjeev Dani, COO and Head, Formulations; Mr. Santhanam Subramanian, CFO; Mr. Swami Iyer; CFO, Aurobindo Pharma USA.

We will begin the call with summary highlights from the management followed by an interactive Q&A session. Please note that some of the matters we will discuss today are forward-looking, including and

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot